Загрузка...
Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer
BACKGROUND: Brain metastasis is common in non-small-cell lung cancer (NSCLC) with driver gene mutations. Anaplastic lymphoma kinase (ALK) gene rearrangement is one of the common driver mutations in NSCLC. Tyrosine kinase inhibitor (TKI) has been the research hotspot at present. However, there are re...
Сохранить в:
| Опубликовано в: : | Oncol Res Treat |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6921697/ https://ncbi.nlm.nih.gov/pubmed/31527380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000502755 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|